| 0Featured |
|
|
12/31/1969 |
| 0Featured |
|
|
12/31/1969 |
| 0Featured |
|
|
12/31/1969 |
| 0Featured |
|
|
12/31/1969 |
| 1 |
1 |
core_concept |
HCV Epidemiology in the United States |
1/2/2024 |
| 1 |
2 |
core_concept |
Recommendations for Hepatitis C Screening |
1/2/2024 |
| 1 |
2 |
URL |
CDC: Know More Hepatitis |
7/3/2013 |
| 1 |
3 |
core_concept |
Hepatitis C Diagnostic Testing |
7/16/2024 |
| 1 |
3 |
URL |
CDC HCV Testing Sequence for Current Infection |
11/11/2020 |
| 1 |
4 |
core_concept |
Counseling for Prevention of HCV Transmission |
1/2/2024 |
| 1 |
4 |
URL |
CDC: Recommendations for Prevention and Control of Hepatitis C Virus |
12/3/2020 |
| 1 |
4 |
URL |
HCV Transmission FAQs |
6/12/2018 |
| 1 |
5 |
core_concept |
Diagnosis of Acute HCV Infection |
1/2/2024 |
| 1 |
5 |
URL |
CDC: Surveillance Guidelines for Acute Hepatitis C |
6/5/2013 |
| 2 |
1 |
core_concept |
Initial Evaluation of Persons with Chronic HCV |
3/16/2024 |
| 2 |
1 |
calculator |
Calculating Body Mass Index (BMI) |
4/8/2021 |
| 2 |
1 |
calculator |
Determining AUDIT-C Score |
3/16/2024 |
| 2 |
2 |
core_concept |
Natural History of HCV Infection |
3/16/2024 |
| 2 |
3 |
core_concept |
Counseling Persons with Chronic HCV Infection |
3/8/2024 |
| 2 |
4 |
core_concept |
Evaluation and Staging of Liver Fibrosis |
3/16/2024 |
| 2 |
4 |
calculator |
Calculating APRI |
10/14/2015 |
| 2 |
5 |
core_concept |
Evaluation and Prognosis of Persons with Cirrhosis |
3/11/2024 |
| 2 |
6 |
core_concept |
Surveillance for Hepatocellular Carcinoma |
4/6/2024 |
| 2 |
7 |
core_concept |
Extrahepatic Conditions Related to HCV Infection |
3/14/2024 |
| 3 |
1 |
core_concept |
Diagnosis and Management of Ascites |
3/4/2024 |
| 3 |
2 |
core_concept |
Recognition and Management of Spontaneous Bacterial Peritonitis |
3/4/2024 |
| 3 |
2 |
URL |
Role of Albumin in Treatment of SBP |
1/16/2021 |
| 3 |
3 |
core_concept |
Screening for Varices and Prevention of Bleeding |
2/27/2024 |
| 3 |
3 |
URL |
Portal Hypertension and Approach to Gastric Varices |
1/16/2021 |
| 3 |
4 |
core_concept |
Diagnosis and Management of Hepatic Encephalopathy |
3/4/2024 |
| 3 |
5 |
core_concept |
Referral for Liver Transplantation |
2/27/2024 |
| 4 |
1 |
core_concept |
Goals and Benefits with HCV Treatment |
4/2/2024 |
| 4 |
2 |
core_concept |
Making a Decision on When to Initiate HCV Therapy |
4/1/2024 |
| 4 |
3 |
core_concept |
Addressing Structural Barriers to HCV Treatment |
4/20/2024 |
| 5 |
1 |
core_concept |
Simplified HCV Treatment for All HCV Genotypes |
9/28/2023 |
| 5 |
2 |
core_concept |
Retreatment of Patients with Prior HCV Treatment Experience |
9/19/2023 |
| 5 |
3 |
core_concept |
Monitoring During and After HCV Treatment |
10/5/2023 |
| 5 |
4 |
core_concept |
Treatment of HCV in Persons with Cirrhosis |
10/5/2023 |
| 5 |
4 |
URL |
Understanding Liver Biopsy Results |
12/10/2020 |
| 5 |
5 |
core_concept |
Treatment of Acute HCV Infection |
10/5/2023 |
| 6 |
1 |
core_concept |
Treatment of HCV in Persons with HIV Coinfection |
1/24/2024 |
| 6 |
1 |
URL |
DHHS Guidelines for HCV-HIV Coinfection |
2/17/2021 |
| 6 |
2 |
core_concept |
Treatment of HCV in Persons with Renal Impairment |
1/24/2024 |
| 6 |
2 |
calculator |
GFR Calculator |
2/20/2021 |
| 6 |
3 |
core_concept |
Treatment of HCV in Persons with Substance Use |
1/25/2024 |
| 6 |
4 |
core_concept |
Treatment of HCV in a Correctional Setting |
1/25/2024 |
| 6 |
5 |
core_concept |
Management of Health Care Personnel Exposed to HCV |
1/26/2024 |
| 6 |
6 |
core_concept |
Perinatal HCV Transmission |
1/27/2024 |
Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir Vosevi